In a recent study, Ye et al. revealed that GOLM1 could drive hepatocellular carcinoma metastasis by modulating EGFR /growth-factor-responsive receptor tyrosine kinase (RTK) cell-surface recycling (Ye et al., 2016). The gene discussed is EGFR; the disease is hepatocellular carcinoma.